Enoxaparin sodium injection BA BE studies [Regulatives / Guidelines]

posted by varsha chungde – India, 2018-10-10 07:11 (878 d 18:15 ago) – Posting: # 19424
Views: 2,300

» You mean solutions. :-D

Yes i mean injectable aqueous solution. As enoxaparin injection is API in aqueous solution. But enoxaparin being a biotech product, i just needed an clarification. Do we need to prove our AP to be similar or good enough to waive the BE studies.

Edit 2018-10-10 07:14: The draft guidance also says to prove the sameness of API. [Varsha]

Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post #5! Merged with a later (deleted) post. You can edit your post within 24 hours. [Helmut]

Complete thread:

 Admin contact
21,371 posts in 4,463 threads, 1,495 registered users;
online 4 (0 registered, 4 guests [including 3 identified bots]).
Forum time: Sunday 00:27 CET (Europe/Vienna)

When people learn no tools of judgment
and merely follow their hopes,
the seeds of political manipulation are sown.    Stephen Jay Gould

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz